LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 21st Prioritisation – 4th quarter 2014

Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 21st Prioritisation – 4th quarter 2014. HSO: 21st Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
92Kb
Abstract

For the 21st prioritisation (December 2014), 12 were filtered out of 169 identified drugs and were sent to prioritisation. Of these, 6 drugs were ranked as "highly relevant" by the expert panel, 5 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
Language:English
Series Name:HSO: 21st Prioritisation
Deposited on:14 Jan 2015 14:42
Last Modified:14 Jan 2015 14:42

Repository Staff Only: item control page